Supported By: GSK
Learning Theater 4
Boston Convention and Exhibition Center

Program Description

IL-5 is a key cytokine mediator in asthma pathophysiology. Many are aware of the effects of IL-5 on eosinophils contributing to the type 2 inflammation that drives the majority of moderate to severe asthma.  New evidence points to a broader and more complex role of IL-5 and its influence on other effector cells including epithelial cells, plasma cells, and fibroblasts. Join us for a review of IL-5 immunology specifically highlighting the multiple effects that contribute to airway remodeling and disease progression.

This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2024 conference sessions. This event is not an endorsement by CHEST and does not reflect the views or opinions of CHEST. This program is sponsored by GSK. The information is scientific and non-promotional in nature.

Speakers

Presenter: Monica Kraft, MD, FCCP
Mount Sinai Health System
Icahn School of Medicine
Professor of Medicine
New York, NY

Presenter: Kathleen Buchheit, MD
Brigham & Women’s Hospital
Division of Allergy & Clinical Immunology
Assistant Professor of Medicine
Boston, MA